Efficacy and safety of telitacicept in the treatment of immunoglobulin a nephropathy: a real-world, single-center, retrospective study

Category Primary study
JournalBMC Nephrol.
Year 2025
This article has no abstract
Epistemonikos ID: d744918582b74c489de4f3ccecf093eabc1149bb
First added on: Jan 09, 2026